126 related articles for article (PubMed ID: 2947742)
21. Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus.
Khan F; Cohen RA; Ruderman NB; Chipkin SR; Coffman JD
Vasc Med; 1996; 1(3):187-93. PubMed ID: 9546937
[TBL] [Abstract][Full Text] [Related]
22. Maintenance of forearm vasodilator action of atrial natriuretic factor in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Kubo SH; Atlas SA; Laragh JH; Cody RJ
Am J Cardiol; 1992 May; 69(16):1306-9. PubMed ID: 1533988
[TBL] [Abstract][Full Text] [Related]
23. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
[TBL] [Abstract][Full Text] [Related]
24. Direct effect of alpha-human atrial natriuretic peptide on human vasculature in vivo and in vitro.
Hughes A; Thom S; Goldberg P; Martin G; Sever P
Clin Sci (Lond); 1988 Feb; 74(2):207-11. PubMed ID: 2962803
[TBL] [Abstract][Full Text] [Related]
25. Lack of venodilative activity of alpha human atrial natriuretic polypeptide in patients with congestive heart failure.
Ikenouchi H; Sato H; Hirata Y; Iizuka M; Serizawa T; Sugimoto T
Jpn Heart J; 1989 Jul; 30(4):443-57. PubMed ID: 2530371
[TBL] [Abstract][Full Text] [Related]
26. Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model.
Vanmolkot FH; Van der Schueren BJ; de Hoon JN
Clin Pharmacol Ther; 2006 Mar; 79(3):263-73. PubMed ID: 16513450
[TBL] [Abstract][Full Text] [Related]
27. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.
Nakamura M; Arakawa N; Yoshida H; Makita S; Hiramori K
Circulation; 1994 Sep; 90(3):1210-4. PubMed ID: 8087930
[TBL] [Abstract][Full Text] [Related]
28. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans.
Schmitt M; Broadley AJ; Nightingale AK; Payne N; Gunaruwan P; Taylor J; Lee L; Cockcroft J; Struthers AD; Frenneaux MP
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1833-8. PubMed ID: 12842844
[TBL] [Abstract][Full Text] [Related]
29. Atrial natriuretic factor potentiates the human forearm vasoconstrictor response to sympathetic stimulation.
Jansen TL; Smits P; Lenders JW; Jacobs MC; Willemsen J; Thien T
Clin Sci (Lond); 1994 Mar; 86(3):275-83. PubMed ID: 8156738
[TBL] [Abstract][Full Text] [Related]
30. [Effects of human atrial natriuretic peptide on hemodynamics and pulmonary gas exchanges in cardiac surgery patients].
Kaneko S; Watanabe S; Kano T
Masui; 1997 Nov; 46(11):1487-91. PubMed ID: 9404133
[TBL] [Abstract][Full Text] [Related]
31. Characterization of ATP-induced vasodilation in the human forearm vascular bed.
Rongen GA; Smits P; Thien T
Circulation; 1994 Oct; 90(4):1891-8. PubMed ID: 7923677
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man.
Weidmann P; Hellmueller B; Uehlinger DE; Lang RE; Gnaedinger MP; Hasler L; Shaw S; Bachmann C
J Clin Endocrinol Metab; 1986 May; 62(5):1027-36. PubMed ID: 2937799
[TBL] [Abstract][Full Text] [Related]
33. [Hemodynamic effects of infusions of alpha-human atrial natriuretic peptide in anesthetized dogs].
Takeda S; Tomaru T; Inada Y
Masui; 1992 Apr; 41(4):566-77. PubMed ID: 1533691
[TBL] [Abstract][Full Text] [Related]
34. The renal, cardiovascular and hormonal actions of human atrial natriuretic peptide in man; effects of indomethacin.
Miyamori I; Ikeda M; Matsubara T; Okamoto S; Koshida H; Yasuhara S; Morise T; Takeda R
Br J Clin Pharmacol; 1987 Apr; 23(4):425-31. PubMed ID: 2953384
[TBL] [Abstract][Full Text] [Related]
35. Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans.
Warren JB; Cockcroft JR; Larkin SW; Kajekar R; Macrae A; Ghatei MA; Bloom SR
J Cardiovasc Pharmacol; 1992 Jul; 20(1):83-7. PubMed ID: 1383635
[TBL] [Abstract][Full Text] [Related]
36. Vascular responses to local atrial natriuretic peptide infusion in man.
Webb DJ; Benjamin N; Allen MJ; Brown J; O'Flynn M; Cockcroft JR
Br J Clin Pharmacol; 1988 Sep; 26(3):245-51. PubMed ID: 2972307
[TBL] [Abstract][Full Text] [Related]
37. Forearm vasodilator mechanisms during mental stress: possible roles for epinephrine and ANP.
Lindqvist M; Kahan T; Melcher A; Bie P; Hjemdahl P
Am J Physiol; 1996 Mar; 270(3 Pt 1):E393-9. PubMed ID: 8638683
[TBL] [Abstract][Full Text] [Related]
38. Local forearm vasodilation with intra-arterial administration of enalaprilat in humans.
Bank AJ; Kubo SH; Rector TS; Heifetz SM; Williams RE
Clin Pharmacol Ther; 1991 Sep; 50(3):314-21. PubMed ID: 1655327
[TBL] [Abstract][Full Text] [Related]
39. Aging and endothelial function in normotensive subjects and patients with essential hypertension.
Taddei S; Virdis A; Mattei P; Ghiadoni L; Gennari A; Fasolo CB; Sudano I; Salvetti A
Circulation; 1995 Apr; 91(7):1981-7. PubMed ID: 7895356
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of coronary conductance by alpha-human atrial natriuretic polypeptide without effects on myocardial contractility.
Shimizu A; Ueeda M; Watanabe H; Hina K; Yamada N; Kusachi S; Saito D; Haraoka S; Tsuji T
Arzneimittelforschung; 1988 Nov; 38(11):1572-7. PubMed ID: 2975170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
